Skip to main content
SpringerLink
Log in

Die Therapie der gestörten Frühschwangerschaft

  • Chapter
  • First Online:
Schwangerschaftsabbruch und gestörte Frühschwangerschaft

  • 2015 Accesses

Zusammenfassung

Eine gestörte Frühschwangerschaft ist eine sehr häufige Diagnose. Von den klinisch nachgewiesenen Schwangerschaften enden etwa 10–15 % vor der 12. Schwangerschaftswoche, ein Großteil vor Ende der 8. Woche [1,2]. Etwa jede 5. – 6. Frau erlebt mindestens einmal in ihrem Leben eine Fehlgeburt [3]. Dabei ist die Ursache in 50–60 % eine spontane genetische Mutation und wiederholt sich nicht [4]. Es erfordert Empathie und Einfühlungsvermögen, um mit der Patientin gemeinsam zu entscheiden, wie das weitere Vorgehen ist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 34.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 44.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. García-Enguídanos A, Calle ME, Valero J, Luna S, Domínguez-Rojas V (2002 May 10) Risk Factors in Miscarriage: A Review. Eur J Obstet Gynecol Reprod Biol 102(2):111–119

    Article  Google Scholar 

  2. Tong S, Kaur A, Walker SP, Bryant V, Onwude JL, Permezel M (2008 Mar) Miscarriage Risk for Asymptomatic Women After a Normal First-Trimester Prenatal Visit. Obstet Gynecol 111(3):710–714

    Article  Google Scholar 

  3. Moradinazar M, Najafi F, Moradi Nazar Z, Hamzeh B, Pasdar Y, Shakiba E (2020 Apr) Lifetime Prevalence of Abortion and Risk Factors in Women: Evidence From a Cohort Study. J Pregnancy . 2020 Apr 27;2020:4871494. doi: https://doi.org/10.1155/2020/4871494. eCollection 2020.

  4. van den Berg MM, van Maarle MC, van Wely M, Goddijn M (2012) Genetics of early miscarriage. Biochim Biophys Acta 1822:1951–1959

    Article  Google Scholar 

  5. Ciro L, Jermy K, May C, Costello G, Collins WP, Bourne TH (2002 Apr 13) Outcome of Expectant Management of Spontaneous First Trimester Miscarriage: Observational Study. BMJ 324(7342):873–875

    Article  Google Scholar 

  6. Chu JJ, Devall AJ, Beeson LE, Hardy P, Cheed V, Sun Y et al (2020) Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomized, double-blind, placebo-controlled trial. The Lancet 396 (10253): 770–778, SEPTEMBER 12, 2020

    Google Scholar 

  7. Rawnaq T (2016) Operatives versus exspektatives Vorgehen beim Management von spontanen Fehlgeburten im ersten Trimenon. Gynakol Geburtsmed Gynakol Endokrinol 2016; 12(3): 246–260 publiziert 30.11.2016 www.akademos.de/gyn ©akademos Wissenschaftsverlag 2016 ISSN 1614–8533

  8. Kim C, Barnard S, Neilson JP, Hickey M, Vazquez JC, Dou L (2017) Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev 1(1):CD007223. Published 2017 Jan 31. doi:https://doi.org/10.1002/14651858.CD007223.pub4

  9. Beucher G, Dolley P, Carles G, Salaun F, Asselin I, Dreyfus M (2014 Feb) Misoprostol: Off-Label Use in the First Trimester of Pregnancy (Spontaneous Abortion, and Voluntary Medical Termination of Pregnancy). J Gynecol Obstet Biol Reprod (Paris) 43(2):123–145

    Article  CAS  Google Scholar 

  10. RCOG-Guideline: National Institute for Health and Care Excellence. (2019). Ectopic pregnancy and miscarriage: diagnosis and initial management NICE guideline [NG126]. https://www.nice.org.uk/guidance/ng126. Zugegriffen: 11.März 2021

  11. American College of Obstetricians and Gynecologists (ACOG), Guideline Number 200, Early pregnancy loss (2018) www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2018/11/early-pregnancy-loss. Zugegriffen: 11.März 2021

  12. Royal College of Obstetricians and Gynaecologists (2015) Recovering from surgical management of a miscarriage. Recovering well. RCOG, London

    Google Scholar 

  13. FIGO Dosage Chart: https://www.figo.org/news/misoprostol-dosage-chart-2017. Zugegriffen: 11. März 2021

  14. AWMF Leitlinie Geburtseinleitung vom 1.12.20 www.awmf.org/leitlinien/detail/ll/015-088.html, Zugegriffen: 11.März 2021

  15. WHO Medical management of abortion (2018): Licence: CC BY-NC-SA 3.0 IGO; SBN 978–92–4–155040–6

    Google Scholar 

  16. Recurrent Pregnancy Loss (2017). ESHRE Early Pregnancy Guideline Development Group. Version 2, November 2017. https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Recurrent-pregnancy-loss

  17. AWMF-Leitlinie (2018) Diagnostik und Therapie von Frauen mit wiederholten Spontanaborten. Leitlinie der DGGG, OEGGG und SGGG (S2k-Niveau, AWMF-Registernummer 015/050. https://www.awmf.org/leitlinien/detail/ll/015-050.html

  18. Gilman Barber AR, Rhone SA, Fluker MR (2014 Nov) Curettage and Asherman's syndrome-lessons to (re-) learn? Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstetrique et Gynecologie du Canada : JOGC 36(11):997–1001. doi: https://doi.org/10.1016/s1701-2163(15)30413-8

  19. https://de.wikipedia.org/wiki/Asherman-Syndrom. Zugegriffen: 6. Juni 2021

  20. Coomarasamy A, Williams H, Truchanowicz E, Seed PT, Small R, Quenby S, Gupta P, Dawood F, Koot YE, Bender Atik R et al (2015) A Randomized Trial of Progesterone in Women with Recurrent Miscarriages. N Engl J Med 373: 2141–2148.

    Google Scholar 

  21. Saccone G, Schoen C, Franasiak JM, Scott RT, Berghella V (2017 Feb) Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials Fertil Steril 107(2):430–438.e3. doi: https://doi.org/10.1016/j.fertnstert.2016.10.031.Epub 2016 Nov 22

  22. Haas DM, Hathaway TJ, Ramsey PS (2019) Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology. Cochrane Database Syst Rev. 2019 Nov 20; 2019(11): CD003511.doi: https://doi.org/10.1002/14651858.CD003511.pub5.

Download references

Author information

Authors and Affiliations

  1. Berlin, Deutschland

    Jana Maeffert & Christiane Tennhardt

Authors
  1. Jana Maeffert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christiane Tennhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jana Maeffert .

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Der/die Autor(en), exklusiv lizenziert durch Springer-Verlag GmbH, DE, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Maeffert, J., Tennhardt, C. (2021). Die Therapie der gestörten Frühschwangerschaft. In: Schwangerschaftsabbruch und gestörte Frühschwangerschaft. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-63517-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-63517-9_5

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-63516-2

  • Online ISBN: 978-3-662-63517-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation